Next Article in Journal
Design and Evaluation of Novel Antimicrobial and Anticancer Agents Among Tetrazolo[1,5-c]quinazoline-5-thione S-Derivatives
Previous Article in Journal
Scientia Pharmaceutica, Autorenhinweise 2014
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessReview
Sci. Pharm. 2013, 81(1), 1-14;

Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective

Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research (NIPER), Sector-67, S.A.S Nagar, Punjab-160062, India
Author to whom correspondence should be addressed.
Received: 7 February 2012 / Accepted: 9 October 2012 / Published: 9 October 2012
PDF [99 KB, uploaded 27 September 2016]


Growth of international free trade and inadequate drug regulation have led to the expansion of trade in counterfeit drugs worldwide. Technological protection is seen to be the best way to avoid this problem. Different technologies came into existence like overt, covert, and track and trace technologies. This review emphasises ideal technological characteristics, existing anti-counterfeit technologies, and their adoption in different countries. Developed countries like the USA have implemented RFID while the European trend is towards 2D barcodes. The Indian government is getting sensitised about the extent of the problem and has formulated rules mandating barcodes. Even the pharmaceutical companies have been employing these technologies in order to detain illegitimate drugs in their supply chain.
Keywords: Authentication; Anti-counterfeit technology; RFID; Pedigree; Serialization Authentication; Anti-counterfeit technology; RFID; Pedigree; Serialization
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

BANSAL, D.; MALLA, S.; GUDALA, K.; TIWARI, P. Anti-Counterfeit Technologies: A Pharmaceutical Industry Perspective. Sci. Pharm. 2013, 81, 1-14.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics



[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top